TLDR Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.
This case series from a Canadian dermatology clinic evaluated the real-world use of clascoterone cream 1% in 10 patients with acne vulgaris, ranging from mild to severe. The study found that clascoterone cream, a topical androgen receptor inhibitor, effectively reduced acne severity over time, demonstrating its efficacy and favorable safety profile for patients aged 12 and older. The cream's versatility is highlighted as it can be used alone or with other treatments, helping to mitigate side effects and prevent acne relapse. Additionally, clascoterone shows promise in treating other dermatological conditions, indicating its broader potential in dermatology.
5 citations,
January 2024 in “Journal of the American Academy of Dermatology” Use benzoyl peroxide, retinoids, antibiotics, and isotretinoin for acne, and combine treatments for better results.
[object Object] 5 citations,
May 2020 in “Clinical and Experimental Dermatology” Clascoterone may be a promising treatment for hair loss.
3 citations,
August 2019 in “Journal of The American Academy of Dermatology” Clascoterone safely promotes hair growth similar to minoxidil.
46 citations,
September 2016 in “Clinical, Cosmetic and Investigational Dermatology” Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.
January 2025 in “Dermatology and Therapy” Hormonal therapies effectively treat acne and improve quality of life.
January 2024 in “Journal of Biosciences and Medicines” Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.
[object Object] 1 citations,
January 2022 in “Journal of Biosciences and Medicines” Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.
2 citations,
May 2021 in “Clinical Pharmacology in Drug Development” Clascoterone is safe for the heart, even at high doses.
There are many treatments for common hair loss, but more trials are needed to decide which are best.